🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/02/2018 | 136,38 | 139,22 | 134,77 | 134,93 | -0,87% | 3,26% | 329.800 |
| 15/02/2018 | 137,33 | 137,80 | 133,54 | 136,11 | -0,59% | 3,10% | 356.100 |
| 14/02/2018 | 128,34 | 137,18 | 128,34 | 136,92 | +6,00% | 6,89% | 397.200 |
| 13/02/2018 | 128,33 | 130,05 | 126,65 | 129,17 | -0,25% | 2,65% | 327.700 |
| 12/02/2018 | 129,87 | 132,40 | 127,49 | 129,50 | +0,61% | 3,78% | 381.600 |
| 09/02/2018 | 127,01 | 130,54 | 122,25 | 128,71 | +1,94% | 6,53% | 463.200 |
| 08/02/2018 | 132,70 | 133,74 | 125,98 | 126,26 | -4,53% | 5,85% | 496.500 |
| 07/02/2018 | 130,33 | 133,87 | 129,74 | 132,25 | +0,81% | 3,17% | 351.900 |
| 06/02/2018 | 125,81 | 132,10 | 123,31 | 131,19 | +3,20% | 6,99% | 347.500 |
| 05/02/2018 | 132,21 | 134,61 | 126,68 | 127,12 | -4,64% | 6,00% | 351.300 |
| 02/02/2018 | 135,19 | 136,14 | 131,05 | 133,31 | -2,33% | 3,77% | 404.700 |
| 01/02/2018 | 128,64 | 137,38 | 127,64 | 136,49 | +5,81% | 7,57% | 463.500 |
| 31/01/2018 | 136,67 | 137,32 | 128,79 | 129,00 | -5,13% | 6,24% | 670.500 |
| 30/01/2018 | 137,26 | 137,83 | 135,71 | 135,97 | -1,73% | 1,54% | 467.600 |
| 29/01/2018 | 136,57 | 139,59 | 136,01 | 138,37 | +1,02% | 2,62% | 287.000 |
| 26/01/2018 | 138,64 | 138,98 | 136,19 | 136,97 | -1,05% | 2,01% | 386.800 |
| 25/01/2018 | 139,50 | 141,94 | 137,35 | 138,42 | +0,07% | 3,29% | 297.600 |
| 24/01/2018 | 143,72 | 143,72 | 137,62 | 138,33 | -3,08% | 4,24% | 316.700 |
| 23/01/2018 | 143,12 | 143,73 | 141,62 | 142,72 | -0,52% | 1,47% | 303.600 |
| 22/01/2018 | 139,36 | 143,67 | 139,11 | 143,46 | +2,83% | 3,27% | 257.700 |
| 19/01/2018 | 140,22 | 141,05 | 137,97 | 139,51 | -0,01% | 2,20% | 463.600 |
| 18/01/2018 | 139,50 | 140,58 | 138,00 | 139,53 | -0,56% | 1,85% | 446.900 |
| 17/01/2018 | 135,93 | 143,00 | 135,40 | 140,32 | +3,85% | 5,59% | 633.300 |
| 16/01/2018 | 140,98 | 142,18 | 134,91 | 135,12 | -4,35% | 5,16% | 627.500 |
| 12/01/2018 | 143,31 | 143,45 | 140,43 | 141,27 | -1,16% | 2,11% | 417.200 |
| 11/01/2018 | 147,00 | 147,18 | 141,01 | 142,93 | -2,50% | 4,20% | 601.600 |
| 10/01/2018 | 149,10 | 149,76 | 145,66 | 146,59 | -2,52% | 2,75% | 268.500 |
| 09/01/2018 | 150,10 | 151,37 | 148,54 | 150,38 | +0,35% | 1,89% | 268.500 |
| 08/01/2018 | 150,30 | 150,98 | 148,47 | 149,85 | +0,04% | 1,67% | 291.000 |
| 05/01/2018 | 149,50 | 150,77 | 148,32 | 149,79 | -0,03% | 1,64% | 365.600 |